14 Oct 2019
LML personnel update
The Centre for Law, Medicine and Life Sciences is growing!We are delighted to announce the following appointments:Jennifer Anderson joined LML in October 2019 as a Research Associate. She will work closely with Dr Jeffrey Skopek (LML Deputy Director) on 'Liability for Harms Caused by the Use of AI in Healthcare', a research project funded by a Well…
11 Oct 2019
LML members participate in OECD workshop
From 17-18 September 2019, Dr Kathy Liddell (Director of LML), Prof. Dianne Nicol (LML Visiting Scholar), and Matt Jordan (Collaborative Research Projects Co-ordinator) attended “Collaborative platforms for personalized health: realizing the potential of genomics and biobanks”.This workshop, organised by OECD in collaboration with Vinnova (the Swed…
9 Oct 2019
Dr Liddell attends CSaP workshop on 'Real World Evidence' in the life sciences industry
On Wednesday 25 September, Dr Kathy Liddell (Director of LML) attended 'What's the value of real world evidence in the context of the life sciences industrial strategy?', a CSaP policy workshop organised jointly with the Department for Health and Social Care, and the Office for Life Sciences.Attended by delegates from academia, policy, the NHS, reg…
5 Jul 2019
Artificial Intelligence and Liability - Job Opportunity
The Centre for Law, Medicine and Life Sciences (LML) seeks to appoint a highly motivated and independent Research Associate to join a two-year research project on artificial intelligence and liability.The project will focus in particular on the assignment of liability for harms caused by the use of machine learning algorithms in healthcare. There a…
12 Jun 2019
Dr Liddell to Present at Workshop on Medical Ethics and Compassionate Use in the UK
On 13 June 2019, Dr Kathy Liddell (LML Director) will participate in a workshop on Medical Ethics and Compassionate Use in the UK.The workshop, organised by Roche Products Ltd. and facilitated by the Pembroke Corporate Partnership Programme, aims to design a consistent and sustainable approach for responding to requests to supply medicines to patie…
13 May 2019
Job Opportunity: Research Associate/Senior Research Associate
The Centre for Law, Medicine and Life Sciences and The Healthcare Improvement Studies Institute (in the School of Clinical Medicine) seek to appoint a Research Associate or Senior Research Associate to work on a project exploring the intersection between the law of negligence and the practice of medical diagnosis.The project will investigate and cr…
13 May 2019
Register now for Antimicrobial Resistance Symposium
LML is delighted to announce that registration has opened for the CeBIL Annual Symposium 2019: Legal Innovation to Support the Development of Antimicrobial Drugs.Antimicrobial resistance (AMR) continues to expand, raising the risk of a future public health crisis. Numerous conferences have been organised to address the scientific challenges of AMR,…
3 May 2019
LML members to participate in international think tank: "Legal Boundaries and the 'Human' in Humanity"
From 9-11 June 2019, Dr Jeffrey Skopek (LML Deputy Director) and Dr Rumiana Yotova will participate in an international think tank on "Legal Boundaries and the 'Human' in Humanity" at McGill University. The think tank is being organized by Professor Bartha Knoppers (McGill) and Professor Hank Greely (Stanford).It will bring together a diverse group…
2 May 2019
Fourth article by LML Research Group published in Nature Biotechnology
An LML Research Group has just published its fourth article in Nature Biotechnology: 'After six years, what has been Mayo’s impact on patent applications related to biotech, diagnostics, and personalized medicine?' (available here), examines the impact of the US Supreme Court's decision in Mayo Collaborative Services v. Prometheus Laboratories, In…
2 May 2019
LML members to participate in CeBIL Retreat
From 20-23 May, several LML members will travel to Copenhagen for a retreat hosted by the University of Copenhagen's Centre for Advanced Studies in Biomedical Innovation Law.As part of the CeBIL Collaborative Research Program, LML is responsible for a study investigating new uses for known drugs, and it will contribute to a study on synergy and pol…
2 May 2019
Dr Liddicoat embarks on research trip to Copenhagen
Dr John Liddicoat (LML Senior Research Associate) is set to undertake a three-week research visit to the University of Copenhagen. His research will focus on the repurposing of drugs -- a topic that is of great interest to LML, which is leading the CeBIL study on New Uses.Over the duration of the trip, Dr Liddicoat will collaborate with the Copenh…
1 May 2019
Dr Liddell teaches Law and Emerging Health Technologies Course at University of Melbourne
Dr Kathy Liddell (LML Director) has recently returned from teaching a course on Law and Emerging Health Technologies at the University of Melbourne, strengthening the already substantial links between the LML and Melbourne Law School.The postgraduate course examined ways in which law is affecting, and being affected by, the latest advances in medic…
1 May 2019
LML Research Group published in 'Global Genes' edited collection
A chapter authored by Dr Kathy Liddell (LML Director), Dr John Liddicoat, and Mr Matt Jordan has been published in T Minssen, J R Hermann and J Schovsbo (eds.) Global Genes, Local Concerns- Legal, Ethical and Scientific Challenges in International Biobanking (Edward Elgar Publishing, 2019).The chapter, ‘IP Policies for Large Bioresources: The ficti…
14 Mar 2019
Dr Imogen Goold Delivers 2019 Baron de Lancey Lecture
On Friday March 8th, the LML hosted the 2019 Baron de Lancey Lecture, kindly sponsored by the Ver Heyden de Lancey Fund.This year, Dr Imogen Goold (St Anne's College, University of Oxford) delivered her thought-provoking talk 'Should parents have the final say on the medical treatment of their children?'Dr Goold's talk addressed a question that has…
17 Dec 2018
Nature Biotechnology publishes third article from LML Research Group
The article, titled 'Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?', reveals the results of an empirical investigation about the effects of the US Supreme Court's decision in Association for Molecular Pathology v Myriad Genetics on patent prosecution for nature-based products beyond isolated DNA…
